The sheer complexity of today's pharmaceutical market presents a major challenge to manufacturers operating in this dynamic environment. Many are experiencing difficulty in measuring the market, much less understanding it.
IMS Next-Generation Prescription Services (NGPS) provides our clients with more accurate reflections of the increasingly complex pharmaceutical market, and greater agility to respond to competitors and market events.
IMS NGPS is truly "changing the game."
Comprehensive measures of prescription consumption patterns - across retail, mail and long-term care channels - give unprecedented insight to navigate the complexity, transforming our clients business from a monthly to a weekly cycle - with far-reaching implications for competitiveness and speed-to-market.
Enhancements to core IMS services such as National Prescription Audit (NPA) and Xponent® are designed to deliver benefits in several critical areas:
-
Productivity: Faster, more accurate market views drive more effective, efficient performance management and quicker turnaround of negative trends
-
Products: Improved specialty market coverage that supports strategies to break in to highly targeted therapy areas
-
People: Greater alignment and improved performance with Sales and Marketing enable joint execution of strategy from one consistent number
-
Processes: New flexibility, options and customization to address emerging needs with agility and confidence
To find out more about NGPS please contact us.
